UX016

· Ultragenyx Pharmaceutical Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for UX016, covering 2026-04-06 to 2026-04-06. Get the full timeline:

Most recent: Clinical Trial Update: First-in-human Study of UX016 in GNEM [Phase 1, Phase 2]